Stock analysts at Huntington assumed coverage on shares of National Healthcare Properties (NASDAQ:NHP – Get Free Report) in a research note issued to investors on Friday. The brokerage set an “outperform” rating and a $18.00 price target on the stock. Huntington’s target price would indicate a potential upside of 15.68% from the stock’s previous close.
NHP has been the subject of a number of other reports. BMO Capital Markets started coverage on National Healthcare Properties in a report on Monday, May 18th. They set a “market perform” rating and a $17.00 price target for the company. Citigroup began coverage on National Healthcare Properties in a report on Thursday, May 28th. They set an “outperform” rating on the stock. Robert W. Baird initiated coverage on National Healthcare Properties in a research note on Monday, May 18th. They issued an “outperform” rating and a $17.00 target price for the company. The Goldman Sachs Group assumed coverage on National Healthcare Properties in a research note on Monday, May 18th. They issued a “buy” rating and a $20.00 target price for the company. Finally, Royal Bank Of Canada initiated coverage on National Healthcare Properties in a report on Monday, May 18th. They issued a “sector perform” rating and a $15.00 price target for the company. Six investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, National Healthcare Properties has a consensus rating of “Moderate Buy” and a consensus target price of $17.33.
View Our Latest Research Report on NHP
National Healthcare Properties Trading Up 2.5%
National Healthcare Properties (NASDAQ:NHP – Get Free Report) last posted its quarterly earnings data on Wednesday, May 13th. The company reported ($0.27) earnings per share for the quarter. The firm had revenue of $86.29 million for the quarter.
Recommended Stories
- Five stocks we like better than National Healthcare Properties
- The AI Data Center Boom Is Bigger Than One Stock—These ETFs Spread the Bet
- Palantir’s Wild Ride: Inside the Stock Wall Street Can’t Agree On
- Has Broadcom Become Too Expensive for Its AI Story?
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
Receive News & Ratings for National Healthcare Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Healthcare Properties and related companies with MarketBeat.com's FREE daily email newsletter.
